EQS-Adhoc: Limes Schlosskliniken AG: Preliminary group result 2024 (unaudited) forcast 2025
|
EQS-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Annual Results/Forecast DGAP-Adhoc: Limes Schlosskliniken AG: Preliminary group result 2024 (unaudited) / forecast 2025
Cologne, February, 25, 2025: Against the backdrop of the additional costs caused by the construction of two new clinic locations, the LIMES Group performed solidly in 2024. The LIMES Schlossklinik Mecklenburgische Schweiz, the LIMES Schlossklinik Fürstenhof and the Clinicum Alpinum recorded increases in revenue and earnings with higher patient occupancy. The Paracelsus Recovery Clinic in Zurich performed temporarily weaker, as a result of which we did not quite reach our original projections for 2024. The marketing activities for the PRC Zurich were adjusted. As a result, we had a very good start in 2025. In the current financial year, we will significantly expand the available clinic capacities. The timing of the start of patient occupancy in the new clinics is still subject to uncertainty, as we have only certain influence on the final approval of the clinic concession. Depending on the final granting of the clinic license for the new locations, we expect revenue of around EUR 50 million and EBITDA in the region of EUR 8-9 million in 2025. We assume that the new locations will generate positive profit contributions from 2026.
Brief profile: The LIMES Schlosskliniken Group operates high-quality private clinics for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to subsidies and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de. Your contact person: End of Inside Information
25-Feb-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Limes Schlosskliniken AG |
| Kaiser-Wilhelm-Ring 26 | |
| 50672 Köln | |
| Germany | |
| ISIN: | DE000A0JDBC7 |
| WKN: | A0JDBC |
| Listed: | Regulated Unofficial Market in Dusseldorf |
| EQS News ID: | 2091095 |
| End of Announcement | EQS News Service |
|
|
2091095 25-Feb-2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 8,18 | 11,02 | 23,44 | 28,81 | 37,17 | 37,45 | 50,00 | |
| EBITDA1,2 | 0,26 | 0,84 | 6,02 | 8,65 | 7,67 | 7,05 | 8,70 | |
| EBITDA-Margin3 | 3,18 | 7,62 | 25,68 | 30,02 | 20,64 | 18,83 | 17,40 | |
| EBIT1,4 | -0,54 | -0,43 | 4,53 | 6,00 | 5,03 | 4,29 | 5,75 | |
| EBIT-Margin5 | -6,60 | -3,90 | 19,33 | 20,83 | 13,53 | 11,46 | 11,50 | |
| Net Profit (Loss)1 | -0,83 | -0,69 | 4,11 | 4,86 | 3,91 | 3,23 | 3,90 | |
| Net-Margin6 | -10,15 | -6,26 | 17,53 | 16,87 | 10,52 | 8,63 | 7,80 | |
| Cashflow1,7 | 0,17 | 0,76 | 4,77 | 8,04 | 6,29 | 7,46 | 6,85 | |
| Earnings per share8 | -2,81 | -2,37 | 13,45 | 14,34 | 11,58 | 10,61 | 13,30 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: B-S-H Collegen
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Limes Schlosskliniken | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0JDBC | DE000A0JDBC7 | AG | 98,32 Mio € | 12.10.2018 | Kaufen | 9F28WWVR+CQ |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 20,63 | 23,65 | 0,87 | 62,70 | 4,17 | 13,17 | 2,63 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 06.06.2025 | 01.09.2025 | 12.05.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -7,51% | -2,65% | -0,60% | -0,60% | +214,29% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
